Treatment outcomes of metastatic nonclear cell renal cell carcinoma: A single institution retrospective analysis

INTRODUCTION: Nonclear cell (NCC) metastatic renal cell carcinoma (mRCC) is a biologically heterogeneous entity. We report the outcomes of NCC mRCC treated with first-line vascular endothelial growth factor (VEGF) inhibitors or mammalian target of rapamycin (mTOR) inhibitors at our institute. This i...

Descripción completa

Detalles Bibliográficos
Autores principales: Agarwala, Vivek, Ramaswamy, Anant, Joshi, Amit, Patil, Vijay Maruti, Noronha, Vanita, Menon, Santosh, Popat, B. Palak, Sable, Nilesh, Prabhash, Kumar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2018
Materias:
ORIGINAL ARTICLE: Genitourinary Cancers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6190394/
https://www.ncbi.nlm.nih.gov/pubmed/30430089
http://dx.doi.org/10.4103/sajc.sajc_22_18

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6190394/
https://www.ncbi.nlm.nih.gov/pubmed/30430089
http://dx.doi.org/10.4103/sajc.sajc_22_18

Ejemplares similares